Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest PTC Therapeutics Inc. Stories

2014-03-06 16:27:15

-Conference Call Today at 4:30 pm ET- SOUTH PLAINFIELD, N.J., March 6, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported its financial results for the fourth quarter and full-year ended December 31, 2013. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO "2013 was a landmark year for PTC with significant accomplishments achieved across the organization. Our private financing early in the year combined with a very successful IPO...

2014-02-28 08:25:27

SOUTH PLAINFIELD, N.J., Feb. 28, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will present a company overview at the Cowen & Company 34th Annual Health Care Conference on Wednesday, March 5(th) at 9:20 am ET at the Marriott Copley Plaza Hotel in Boston. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics'...

2014-02-28 00:21:26

SOUTH PLAINFIELD, N.J., Feb. 27, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it granted a non-statutory stock option to purchase 150,000 shares of its common stock to Robert Spiegel, M.D., PTC's newly appointed Chief Medical Officer. The grant was made pursuant to the NASDAQ inducement grant exception as a component of Dr. Spiegel's employment compensation. The inducement grant was approved by PTC's Board of Directors on February 27, 2014 and is...

2014-02-27 20:22:58

SOUTH PLAINFIELD, N.J., Feb. 27, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that will host a webcast conference call to discuss financial results for the fourth quarter and year end 2013 on Thursday, March 6, 2014 at 4:30 p.m. (ET) after the closing of the market. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the...

2014-02-25 08:32:07

SOUTH PLAINFIELD, N.J., Feb. 25, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Guido Schopen, M.D. to General Manager and Head of Medical Affairs for Europe. Dr. Schopen will be responsible for European commercial operations, reporting to Mark Rothera, Chief Commercial Officer of PTC. (Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) "We are delighted to welcome Dr. Schopen to our team where he will play a key leadership role...

2014-02-20 08:31:58

SOUTH PLAINFIELD, N.J., Feb. 20, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will participate in two upcoming investor conferences: (Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO) - Management will participate in a panel entitled "DMD Back in the Spotlight, What's New and What's Different" which will be held from 9:40-10:25am ET on Tuesday, February 25(th) at the 2014 Citi Global Healthcare Conference in New York City. - The...

2014-02-19 12:29:25

SOUTH PLAINFIELD, N.J., Feb. 19, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the closing of its previously announced registered public offering of 5,163,265 shares of its common stock, including 673,469 shares sold by PTC as a result of the full exercise by the underwriters of their option to purchase additional shares, at a price to the public of $24.50 per share. PTC expects its net proceeds from this offering to be approximately $118 million, after...

2014-02-12 20:22:06

SOUTH PLAINFIELD, N.J., Feb. 12, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the pricing of an underwritten public offering of 4,489,796 million shares of common stock at a public offering price of $24.50 per share, before underwriting discounts. All of the shares in the offering are being offered by PTC. In addition, PTC has granted the underwriters an option for a period of 30 days to purchase up to 673,469 additional shares of common stock at the...

2014-02-10 16:27:08

SOUTH PLAINFIELD, N.J., Feb. 10, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has commenced an underwritten public offering of approximately $75 million of shares of its common stock. The number of shares to be offered and the price for the proposed offering have not yet been determined. All of the shares in the offering are to be sold by PTC. PTC intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the...

2014-01-30 08:31:35

SOUTH PLAINFIELD, N.J., Jan. 30, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) is proud to announce that its founder and Chief Executive Officer, Stuart W. Peltz, Ph.D. has been awarded the 2014 Dr. Sol J. Barer Award for Vision, Innovation, and Leadership. Named for Sol J. Barer, Ph.D., founder and former Chairman and Chief Executive Officer of Celgene Corporation of Summit, N.J., the award recognizes outstanding research and business leaders who have made significant...